Programmed Cell Death Ligand 1 Is Enriched in Mammary Stem Cells and Promotes Mammary Development and Regeneration
Programmed cell death ligand 1 (PD-L1) is widely expressed in a variety of human tumors, and inhibition of the PD-L1/PD-1 pathway represents one of the most promising therapy for many types of cancer. However, the physiological function of PD-L1 in tissue development is still unclear, although PD-L1...
Enregistré dans:
Auteurs principaux: | Ruirui Wang, Fujing Huang, Wei Wei, Yu Zhou, Zi Ye, Liya Yu, Junyuan Hu, Cheguo Cai |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/5711ff2a33b74d539d154bba5351f0c2 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Journal of mammary gland biology and neoplasia
Publié: (1996) -
Epidemiological study of canine mammary tumors: age, breed, size and malignancy
par: Pastor,Nieves, et autres
Publié: (2018) -
Evaluation of clinical and pathological characteristics of 155 canines with mammary tumours: a retrospective study
par: Sontas,BH, et autres
Publié: (2009) -
Label-free isolation and cultivation of patient-matched human mammary epithelial and stromal cells from normal breast tissue
par: Maria K. Koch, et autres
Publié: (2021) -
Morphometric and Hormonal Study of the Effect of Utrica diocia Extract on Mammary Glands in Rats
par: Jalili,C, et autres
Publié: (2015)